Patents by Inventor Seth G. Michelson

Seth G. Michelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220093269
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Application
    Filed: December 6, 2021
    Publication date: March 24, 2022
    Applicant: Labrador Diagnostics LLC
    Inventors: Elizabeth A. HOLMES, Ian GIBBONS, Daniel YOUNG, Seth G. MICHELSON
  • Patent number: 11195624
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: December 7, 2021
    Assignee: Labrador Diagnostics LLC
    Inventors: Elizabeth A. Holmes, Ian Gibbons, Daniel Young, Seth G. Michelson
  • Patent number: 11158429
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: October 26, 2021
    Assignee: Labrador Diagnostics LLC
    Inventors: Elizabeth A. Holmes, Ian Gibbons, Daniel Young, Seth G. Michelson
  • Patent number: 11139084
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: October 5, 2021
    Assignee: Labrador Diagnostics LLC
    Inventors: Elizabeth A. Holmes, Ian Gibbons, Daniel Young, Seth G. Michelson
  • Publication number: 20180374582
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Application
    Filed: April 13, 2018
    Publication date: December 27, 2018
    Applicant: Theranos IP Company, LLC
    Inventors: Elizabeth A. HOLMES, Ian GIBBONS, Daniel YOUNG, Seth G. MICHELSON
  • Publication number: 20180308585
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Application
    Filed: April 13, 2018
    Publication date: October 25, 2018
    Applicant: Theranos IP Company, LLC
    Inventors: Elizabeth A. HOLMES, Ian GIBBONS, Daniel YOUNG, Seth G. MICHELSON
  • Publication number: 20170053091
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Application
    Filed: August 24, 2016
    Publication date: February 23, 2017
    Inventors: Elizabeth A. Holmes, Ian Gibbons, Daniel Young, Seth G. Michelson
  • Patent number: 9460263
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: October 4, 2016
    Assignee: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Ian Gibbons, Daniel L. Young, Seth G. Michelson
  • Publication number: 20150100345
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Application
    Filed: October 10, 2014
    Publication date: April 9, 2015
    Inventors: Elizabeth A. Holmes, Ian Gibbons, Daniel L. Young, Seth G. Michelson
  • Patent number: 8862448
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Grant
    Filed: October 18, 2010
    Date of Patent: October 14, 2014
    Assignee: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Ian Gibbons, Daniel L. Young, Seth G. Michelson
  • Publication number: 20110093249
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Application
    Filed: October 18, 2010
    Publication date: April 21, 2011
    Applicant: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Ian Gibbons, Daniel L. Young, Seth G. Michelson
  • Publication number: 20080213786
    Abstract: The invention encompasses a novel method of treating an inflammatory disease, such as rheumatoid arthritis, and novel methods of identifying and screening for drugs useful in the treatment of inflammatory diseases, such as rheumatoid arthritis, and their clinical symptoms. The inventors have made the discovery that the activity of galectin-3, a ?-galactoside-binding lectin known to have an effect on some cancers, has a significant impact on the pathophysiology of rheumatoid arthritis. The symptoms of an inflammatory disease, such as rheumatoid arthritis, may be alleviated by administering a compound that inhibits the activity of galectin-3.
    Type: Application
    Filed: April 11, 2008
    Publication date: September 4, 2008
    Applicant: Entelos, Inc.
    Inventors: Vincent Jacques Hurez, Seth G. Michelson, Herbert Struemper, Leif Gustaf Wennerberg
  • Publication number: 20080118466
    Abstract: The invention encompasses novel methods of treating rheumatoid arthritis and its symptoms and novel methods of identifying and screening for drugs useful in the treatment of rheumatoid arthritis and its clinical symptoms. Targeted manipulation of a computer model of a human rheumatic joint provided the surprising result that cross-linking soluble Fas-ligand (sFasL) has a significant impact on the pathophysiology of rheumatoid arthritis. The symptoms of rheumatoid arthritis may be alleviated by administering a sFasL-specific cross-linker.
    Type: Application
    Filed: June 8, 2007
    Publication date: May 22, 2008
    Inventors: Vincent Jacques Hurez, Seth G. Michelson, Lisl Katharine Shoda, Herbert Struemper, Leif Gustaf Wennerberg